CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer (clinicaltrials.gov) - Apr 28, 2026 - P1 | N=42 | Recruiting | Sponsor: Washington University School of Medicine | Trial completion date: Jun 2028 ➔ Apr 2029 | Trial primary completion date: Sep 2027 ➔ Jul 2028
Trial completion date • Trial primary completion date • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Oncology • Solid Tumor • HER-2
|